Knowles Corp (KN) Knowles Corporation is a leading provider of specialized electronic components, offering an array of micro-acoustic microphones, sophisticated balanced armature speakers, comprehensive audio solutions, high-performance capacitors, and advanced radio frequency products. These precision technologies serve diverse industries, including consumer electronics, medical technology (medtech), defense, electric vehicles, industrial applications, and communications. The company operates through two distinct segments. Its Audio segment is dedicated to engineering and manufacturing innovative audio components, such as microphones, balanced armature speakers, and audio processors. These are integral to applications across mobile devices, hearing health solutions, True Wireless Stereo (TWS) products, the Internet of Things (IoT), and computing platforms. Concurrently, the Precision Devices (PD) segment focuses on the development and delivery of high-specification capacitor products and RF solutions. These critical components find use in demanding applications like power supplies, medical implants, satellite communications, radar systems, and general communications equipment. Knowles distributes its offerings directly to original equipment manufacturers (OEMs), their contract manufacturers, and suppliers, as well as through an established network of distributors. With a global footprint spanning Asia, the United States, Europe, and other parts of the Americas, the company, established in 1946, maintains its headquarters in Itasca, Illinois.
Sector: Household Audio & Video Equipment
Industry: Hardware, Equipment & Parts
Knowles Corporation NYSE:KN Technology · Hardware, Equipment & Parts
AH Close $32.17 +0.00% vs close
AH Close $32.17 +0.00% vs close
All Press Release SEC Filings News
Press Release ● Major ⚠ 2
Knowles Reports Q3 2026 Financial Results and Provides Outlook for Q4 2026
Knowles reported Q3 2026 revenue of $184 million, up 20% year-over-year and above the high end of guidance, with GAAP diluted EPS of $0.24 and non-GAAP EPS of $0.38.
Q3 operating cash flow was $45 million, adjusted EBITDA was $48.3 million (26.3% of revenue), and adjusted free cash flow was $42.6 million.
Management guided Q4 revenue to $180-$190 million with non-GAAP EPS of $0.39-$0.43, implying full-year 2026 revenue of roughly $689 million, up 16% versus 2025.
The CEO said order strength persists — Precision Devices book-to-bill has been above one for eight straight quarters — and that 2027 results should exceed the May 2025 Investor Day growth targets.
• 3d ago AI analysis › Press Release
Knowles Expands RF Signal Chain Offering with New A-Series Attenuators
Knowles launched its ATT A-Series surface mount attenuators, extending its RF portfolio with broadband performance from DC to 20 GHz.
The thin-film attenuators offer up to 6.5 W CW power handling at 100°C, an operating range of -55°C to +125°C, and standard attenuation from 0 dB to 20 dB in a compact 2.03 x 1.65 x 0.30 mm package.
Target applications span radar, phased-array antennas, SATCOM, and wireless infrastructure, and the parts are pin-compatible with industry-standard chip attenuators for a low-friction upgrade path.
• 25d ago AI analysis › Press Release
Knowles to Release Third Quarter 2026 Financial Results on October 22, 2026
Knowles Corporation announced it will release third quarter 2026 financial results on October 22, 2026, after market close.
A conference call to discuss results and the company outlook is scheduled for 3:30 p.m. Central time (4:30 p.m. Eastern) the same day, with a webcast replay available on the investor relations site.
This is a scheduling notice only and contains no financial results or guidance.
• 26d ago AI analysis › Press Release
Elucent Medical Selects Knowles Corporation to Manufacture Advanced Surgical Guidance Device
Knowles Corporation announced an agreement with Elucent Medical to manufacture a smart surgical guidance device used with the EnVisio In-Body Spatial Intelligence System.
The partnership leverages Knowles' micro molding and design-for-manufacturability expertise to accelerate production and improve product reliability.
Production will be conducted at one of Knowles' ISO 13485-certified and FDA-registered facilities in Penang, Malaysia.
• 2mo ago AI analysis › SEC Filing
KN: 8-K/A · proxy statement
Knowles Corporation filed an amendment to its April 29, 2026 Form 8-K to disclose its decision on the frequency of future Say-on-Pay votes. The company stated that following the 2026 annual meeting, the board determined it will hold these votes annually until the next stockholder advisory vote on frequency occurs no later than the 2032 annual meeting.
This decision follows a non-binding advisory vote at the annual meeting where "every year" received the highest number of votes cast. The amendment clarifies the governance outcome without introducing any other changes to the original report.
SEC 8-K/A • 2mo ago SEC Filing
KN: 10-Q · periodic report
Knowles reported second quarter 2026 revenues of $166.8 million, an increase of 14.3% from the prior year, driven primarily by higher demand in the Precision Devices segment. The Precision Devices segment grew revenue by 25.2% to $98.3 million, fueled by industrial, electrification, medtech, and defense markets, while the MedTech & Specialty Audio segment saw a modest 1.6% increase.
Profitability improved significantly, with net earnings rising to $19.4 million, or $0.22 per diluted share, compared to $7.8 million, or $0.09 per share, in the same period last year. Gross margin expanded to 44.7% from 41.5%, supported by higher shipping volumes, pricing, and increased factory capacity utilization, partially offset by unfavorable product mix.
The company continued its capital allocation strategy, repurchasing $22.5 million of common stock during the six months ended June 30, 2026, leaving $106.5 million remaining under its authorization. Knowles ended the quarter with $49.6 million in cash and cash equivalents and $131.0 million in long-term debt.
SEC 10-Q • 2mo ago AI analysis › Press Release ● Major
Knowles Reports Q2 2026 Financial Results and Provides Outlook for Q3 2026
Knowles delivered strong Q2 results with revenue rising 14% year-over-year to $166.8 million and Non-GAAP diluted EPS increasing 38% to $0.33, exceeding the high end of the company's guided range.
Management highlighted broad-based growth across the Precision Devices segment in Medtech, Defense, and Industrial markets, marking the seventh consecutive quarter with a book-to-bill ratio greater than one.
Looking ahead, the company raised its outlook for 2026, projecting revenue growth of 10-12% and adjusted EBITDA growth of more than 20% while initiating Q3 revenue guidance of $167 million to $177 million.
• 3mo ago AI analysis › Press Release
Knowles to Release Second Quarter 2026 Financial Results on July 23, 2026
Knowles Corporation scheduled the release of its second quarter 2026 financial results for July 23, 2026, immediately after market close.
A conference call to discuss the results and company outlook will follow at 4:30 p.m. Eastern time.
Investors can access the live webcast or dial-in via the details provided in the release.
• 3mo ago AI analysis › Press Release ● Major
Knowles Reports Q1 2026 Financial Results and Provides Outlook for Q2 2026
Knowles reported Q1 2026 revenue of $153.1 million, up 16% year-over-year, with non-GAAP diluted EPS increasing 50% to $0.27.
The company stated that results were at or above the high-end of guided ranges, driven by strong secular growth trends in Medtech, Defense, Industrial, and Electrification end markets.
For Q2 2026, Knowles expects revenue of $152 to $162 million and diluted EPS from continuing operations of $0.18 to $0.22 GAAP and $0.28 to $0.32 non-GAAP.
• 6mo ago AI analysis › Recent SEC filings with analysis 
